Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
about
Lipid-lowering efficacy of atorvastatinStatins for preventing colorectal adenoma and carcinomaC-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection StudyStatins research unfinished saga: desirability versus feasibilityReview of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesManagement of intracerebral hemorrhage--use of statinsStatin use in prediabetic patients: rationale and results to dateStatins in heart failure: do we need another trial?Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons.Pediatric Statin Administration: Navigating a Frontier with Limited DataNew Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple SclerosisA systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscleDifferential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sitesCholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort studyPitavastatin and carbohydrate metabolism: what is the evidence?Rosuvastatin protects against podocyte apoptosis in vitroAngiogenesis, neurogenesis and brain recovery of function following injuryInhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ ExpressionAssociation of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase InhibitorsCo-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.Environmental and genetic factors affecting transport of imatinib by OATP1A2Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.Statins and neuroprotection: a prescription to move the field forwardStatin induced diabetes and its clinical implications.Effects of statins on skeletal muscle: a perspective for physical therapists.Lipophilic statin use and risk of breast cancer subtypes.Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.A circadian gene expression atlas in mammals: implications for biology and medicine.Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts.Statins and risk of cancer: a systematic review and metaanalysis.Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.Molecular mechanisms underlying the effects of statins in the central nervous system.Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memoryStatin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort studyRole of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse.Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.
P2860
Q24187301-0AD58C59-BD8D-4984-B382-30DB7D86A02CQ24194802-8E1DD23D-9478-4695-BAC9-650C9C875768Q24617734-FB15C48A-4229-47B2-B501-77BD1D040728Q24811267-3B66AE68-7EBB-483A-869D-E91AE27B6254Q26746907-749704AB-E746-4FE2-9568-AB03A384E625Q26752952-3BCC876D-FCE1-49D9-A5CC-2EB5A134E660Q26786008-B8A9F3D3-5D94-445B-B3B2-17E6884B93C5Q26998966-67946ED6-5483-4F48-9F95-1D4D9BD38103Q27307798-A0D26FF9-CE28-4A77-894E-62EF40929A01Q28068014-33D9EF85-2E7D-4659-B426-602A9F3D4843Q28072844-98E7D759-E741-4EF3-856E-80EB77DC48A9Q28469099-F1D70CCE-D028-4703-83A1-989911FEC9A0Q28478551-11364EB1-668C-4554-8A84-C22C82CC4A0CQ28740349-5D70873C-DE3D-4764-BA79-9B675BB49F4EQ30251801-6A84B525-60EC-40D7-BDDF-7F381312E923Q33372307-ACD49776-CC88-4799-A3C5-9CB15FE64A84Q33718009-1F67536F-199F-41F9-8FE7-E8157DE271CBQ33755131-7BA31463-76F8-455D-B92A-4CE69AD7C743Q33763342-C4BF6AFD-A7BE-4F24-A210-93DD49EA63D0Q33861870-FD75F419-DAEA-48EE-A709-77A541DB94FAQ33878471-2434A341-4869-4F19-A969-4C0C781EFD53Q33925913-32D8172F-9260-4FC9-9F9A-FAB5AAF55B5BQ34015831-D52F5BFC-7494-4C6A-8615-6F0DC5D213E1Q34145046-0B259ACE-B3B9-40DE-98E1-97A73D20DFBFQ34173180-D4C1A53C-0BD6-4A23-9568-6A7DF4838BAFQ34185642-FD0D13B0-63A5-4428-9184-8776E55C6580Q34219598-DB331DEC-67C7-4538-982F-CE7605412343Q34429685-38E5E45C-4D50-47B3-B257-C87774E898F8Q34445166-54179A82-D30E-479C-BCEE-1096CD3080F1Q34451383-B00D60A6-318C-43DD-B0F4-438F5B36BD4EQ34531158-342580D9-C198-4BA6-8499-A60D9576AEA1Q34538139-85624DE0-48E5-40C7-B618-0D14BAEC0A91Q34585294-F800A8F8-F8CA-4468-93E3-BEDFC613D274Q34618889-9F06DE72-DA63-4591-8793-EDD99BFB687CQ34685463-C892CFE4-6B69-4283-9EF9-8D7DEBA9B8BDQ34990621-3B78B9FB-C0B2-4A48-BC94-0F99F82D495EQ34998527-172BCFCE-A04F-4C78-B5F3-1B633330B8B4Q35002429-9CD21049-1382-4A31-B468-7B22CB377FA5Q35115534-DB1EFD67-84CE-43F9-ADF5-615FC0DD5C3DQ35159559-6D21DAAE-7268-4EEE-B927-11DCEC91C62B
P2860
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@ast
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@en
type
label
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@ast
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@en
prefLabel
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@ast
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@en
P1476
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
@en
P2093
Michael Schachter
P304
P356
10.1111/J.1472-8206.2004.00299.X
P577
2005-02-01T00:00:00Z